LOS ANGELES, Nov. 09, 2026 (GLOBE NEWSWIRE) -- Investors in The Chemours Company ("Chemours" or the "Company") (NYSE:CC) have until December 7, 2026 to ask the Court to appoint them lead plaintiff in a
NEW YORK, Nov. 09, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP highlights the alleged Chemours promise-reality gap at the center of a securities fraud class action pending on behalf of investors who suffered
SAN DIEGO, Nov. 09, 2026 (GLOBE NEWSWIRE) -- Shareholder rights law firm Robbins LLP reminds investors that a class action was filed on behalf of persons or entities who purchased or otherwise acquired The Chemours
NEW YORK, Nov. 09, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against The Chemours Company (NYSE:CC) and certain of the
NEW YORK and NEW ORLEANS, Nov. 6, 2026 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses
CC INVESTOR ALERT
NEW YORK CITY, NY / ACCESS Newswire / November 6, 2026 / Levi & Korsinsky, LLP alerts investors in The Chemours Company (NYSE:CC) of a pending securities class action concerning the specialty
New York, New York--(Newsfile Corp. - November 6, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against The Chemours Company ("Chemours" or the "Company")
NEW YORK, Nov. 06, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against The Chemours Company (NYSE:CC) and certain of the
NEW ORLEANS, Nov. 05, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until December 7, 2026 to file lead plaintiff applications in a securities class
Time-Sensitive: Allegations Focus on 2026 EBITDA Guidance Representations. The lawsuit asserts that Chemours reaffirmed a full-year outlook that allegedly ignored aftermarket prebuy activity, which pulled Opteon
Complaint alleges The Chemours Company misled investors between February 20, 2026 and August 4, 2026; investors may seek lead plaintiff role by December 7, 2026LOS ANGELES, Nov. 4, 2026 /PRNewswire/ -- Glancy Prongay
New York, New York--(Newsfile Corp. - November 4, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against The Chemours Company ("Chemours" or the "Company")
NEW YORK, Nov. 04, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against The Chemours Company (NYSE:CC) and certain of the
NEW YORK, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against The Chemours Company ("Chemours " or the "Company") (NYSE:CC) and certain
Suit alleges The Chemours Company failed to disclose key facts to investors from February 20, 2026 through August 4, 2026; lead plaintiff deadline is December 7, 2026BENSALEM TOWNSHIP, Pa., Nov. 3, 2026 /PRNewswire/ --
